ArticleJournal of managed care & specialty pharmacy2025

Comparative real-world survival of first-line atezolizumab, nivolumab, and pembrolizumab in older patients with metastatic non-small cell lung cancer.

Xiangzhong Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.